Octopus Biosafety (STU:OCR) ROCE %: 0.00% (As of Dec. 2024)


STU:OCR Octopus Biosafety STU:OCR
11 GF Score
Price €0.10
GF Value €0.05
! 2 Warning Signs
View Full Analysis

What is Octopus Biosafety ROCE %?

Octopus Biosafety STU:OCR 11 ROCE % is 0.00% as of Dec. 2024. GuruFocus rates STU:OCR with a GF Score™ of 11/100 and a GF Value™ of €0.05. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Octopus Biosafety's annualized ROCE % for the quarter that ended in Dec. 2024 was 0.00%.

Octopus Biosafety  (STU:OCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Octopus Biosafety ROCE % Related Terms

Octopus Biosafety ROCE % Historical Data

* Premium members only.

The historical data trend for Octopus Biosafety's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Octopus Biosafety ROCE % Chart

Octopus Biosafety Annual Data
Trend Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -189.07 -194.61 0.00 0.00 0.00

Octopus Biosafety Semi-Annual Data
Jun14 Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only -189.07 -194.61 0.00 0.00 0.00
STU:OCR
11GF Score
Octopus Biosafety STU:OCR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Octopus Biosafety ROCE % Calculation

Octopus Biosafety's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-0.837/( ( (0.771 - 0.433) + (0.489 - 0.985) )/ 2 )
=-0.837/( (0.338+-0.496)/ 2 )
=-0.837/-0.079
=1,059.49 %

Octopus Biosafety's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2024 )  (Q: Dec. 2023 )(Q: Dec. 2024 )
=-0.837/( ( (0.771 - 0.433) + (0.489 - 0.985) )/ 2 )
=-0.837/( ( 0.338 + -0.496 )/ 2 )
=-0.837/-0.079
=0 %

(1) Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Octopus Biosafety (STU:OCR) has a ROCE % of 0.00% as of Dec. 2024.
Is Octopus Biosafety's ROCE % too high?
Octopus Biosafety's current ROCE % is 0.00%. Overall, Octopus Biosafety has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's ROCE % compare to DELL and SNDK?
Octopus Biosafety's ROCE % of 0.00% can be compared against companies in the Hardware industry. The industry median ROCE % is 5.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Hardware company?
The median ROCE % among Hardware companies is 5.83, based on 2,445 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Hardware industry, the median ROCE % is 5.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current ROCE % of 0.00%. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current ROCE % is 0.00%. Octopus Biosafety's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current ROCE % is 0.00% as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Octopus Biosafety (STU:OCR) Overvalued in 2026?

Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued. The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.

Key valuation signals for STU:OCR:

  • ROCE %: 0.00%
  • GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
  • GF Score™: 11/100 with 2 warning signs

No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Octopus Biosafety Business Description

Other Exchanges MLOCT:France
Address 29 rue Saint Pierre, Cholet, FRA, 49300
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
11GF Score

Get the complete analysis for STU:OCR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.05
GF Value